MicroRNA-29a Protects Against Acute Liver Injury in a Mouse Model of Obstructive Jaundice Via Inhibition of the Extrinsic Apoptosis Pathway
Authors
Affiliations
Recent studies have shown that microRNA-29 (miR-29) is significantly decreased in liver fibrosis, as demonstrated in human liver cirrhosis, and that its downregulation influences the activation of hepatic stellate cells. In addition, both cleaved caspase-3 production and apoptosis play a role in cholestatic liver injury. However, it is unknown if miR-29 is effective in modulating the extent of injury. We employed miR-29a transgenic mice (miR-29aTg mice) and wild-type (WT) littermates to clarify the role of miR-29 in hepatic injury and fibrogenesis, using the bile duct-ligation (BDL) mouse model. After BDL, all three members of the miR-29 family were significantly downregulated in the livers of WT mice, and miR-29b and miR-29c were significantly downregulated in the livers of the miR-29aTg mice. Liver function, as measured by alanine transaminase and aspartate transaminase activity, was significantly improved in the miR-29aTg mice than in the WT littermates, following 1 week of obstructive jaundice. In addition, overexpression of miR-29a was associated with a significant downregulation of the expression of collagen-1α1, collagen-4α1, phospho-FADD, cleaved caspase-8, cleaved caspase-3, Bax, Bcl-2, PARP, and nuclear factor-κB, as well as an upregulation of phospho-AKT expression. In addition, there were significantly fewer TUNEL-positive liver cells in the miR-29aTg group than in the WT littermates after BDL. Our results indicate that miR-29a decreases cholestatic liver injury and fibrosis after BDL, at least partially, by modulating the extrinsic rather than intrinsic pathway of apoptosis.
Xiang D, Liu J, Zhong Z, Xiong Y, Kong H, Yu H Curr Med Sci. 2023; 43(3):456-468.
PMID: 37115401 DOI: 10.1007/s11596-023-2734-5.
Lee H, Song S, Hwang J, Baek A, Baek D, Kim S Front Mol Neurosci. 2023; 15:1019173.
PMID: 36824441 PMC: 9942523. DOI: 10.3389/fnmol.2022.1019173.
Serum non-coding RNAs for diagnosis and stage of liver fibrosis.
Liu C, Hou X, Mo K, Li N, An C, Liu G J Clin Lab Anal. 2022; 36(10):e24658.
PMID: 35989522 PMC: 9550980. DOI: 10.1002/jcla.24658.
Huang Y, Wang F, Wang P, Lin H, Luo S, Yang Y Int J Mol Sci. 2022; 23(1).
PMID: 35009003 PMC: 8745303. DOI: 10.3390/ijms23010577.
Impedes Metastatic Behaviors in Hepatocellular Carcinoma via Targeting , , and .
Yang Y, Tsai M, Chang Y, Wang C, Chu P, Lin H Int J Mol Sci. 2021; 22(11).
PMID: 34206143 PMC: 8199573. DOI: 10.3390/ijms22116001.